Esperion Therapeutics ESPR Accrued legal fees
Accrued legal fees at other companies
Other financials
Where this comes from
Reported directly by Esperion Therapeutics in its filing.
Tagged under the XBRL concept espr:AccruedLegalFeesCurrent.
The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Esperion Therapeutics's accrued legal fees.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Esperion Therapeutics's accrued legal fees?
- Esperion Therapeutics (ESPR) reported accrued legal fees of $4.84M in Q1 2026.
- How has Esperion Therapeutics's accrued legal fees changed year-over-year?
- Esperion Therapeutics's accrued legal fees increased by 123.7% year-over-year, from $2.16M to $4.84M.
- What is the long-term trend for Esperion Therapeutics's accrued legal fees?
- Over 3 years (2022 to 2025), Esperion Therapeutics's accrued legal fees has grown at a 131.8% compound annual growth rate (CAGR), from $186K to $2.32M.
- What does accrued legal fees mean?
- This represents the current liability for legal services that have been performed but not yet invoiced or paid. It reflects the company's ongoing commitment to legal counsel and potential litigation-related expenses. Tracking this provides insight into the company's short-term legal obligations and potential exposure to regulatory or contractual disputes.